Article may be outdated

This article is 13 days old. Some details may have changed since publication.

Hacker News·2 min read·hard

Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression

C
cpncrunch
AI Summary

This article discusses the clinical efficacy and safety profile of psilocybin as a treatment for major depression that has proven resistant to traditional therapies. It examines the results of recent studies regarding the therapeutic potential of psychedelic-assisted therapy.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in

Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression — Headlinne — headlinne